Skip to content
Disclosery

Sozo Ventures GP II, L.P.

Follow

13F filer, CIK 1912294, REDWOOD CITY, CA

Sozo Ventures GP II, L.P. reported $1,331,404 across 1 holding for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-06.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-107211

Period
2025-09-30
Reported value
$1.33M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001104659-25-107211, largest first. % of portfolio is the value over $1,331,404, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MGXMETAGENOMI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: not reported; 2024Q1: 581,577 shares; 2024Q2: 581,577 shares; 2024Q3: 581,577 shares; 2024Q4: 581,577 shares; 2025Q1: 581,577 shares; 2025Q2: 581,577 shares; 2025Q3: 581,577 shares 581,577$1.33M100%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-25-107211 base2025-11-06acceptance time not in the bulk data set